Current issues of regulating the development of the Russian pharmaceutical market

Introduction. The relevance of regulating the pharmacy sector in Russia is growing against the backdrop of a dynamic pharmaceutical market facing problems with the availability of drugs and the influence of network structures.The study aims to analyze the legal regulation and prospects of the pharmacy sector. Objective of the study. Conducting an analysis of the directions and features of legal regulation of the Russian pharmaceutical market, taking into account the existing risks and prospects for the development of the pharmacy sector, the availability of drug supply. Material and methods. The materials were regulatory legal acts, results of analytical research of the pharmaceutical market, data from the register of licenses of Roszdravnadzor. The research methods included content analysis of regulatory legal acts and literature sources in the field of drug circulation, regulation of competitive markets, methods of retrospective, statistical, comparative and forecast analysis. Results. The analysis of the pharmaceutical market revealed problems associated with its monopolization and reduced availability of drug care for some categories of citizens. The main problems include imbalance among market participants, territorial unevenness of pharmacy infrastructure and the lack of unified mechanisms for approaches to regulation for the state segment. The article presents an analysis of changes in legislation on regulating the pharmaceutical market, taking into account the main trends in the development of the pharmacy sector and the availability of drug provision. The vector of legal regulation aimed at increasing the availability of drug care and counteracting the monopolization of the market is noted. The problems of regulating pharmacy chains are identified due to the imperfect terminology, the lack of a differentiated approach when introducing the proposed antimonopoly restrictions. The risks of negative consequences for the development of individual market participants, including in the state segment, the availability of drug care in remote and sparsely populated areas are predicted. Conclusion. The key problems associated with the specifics of the current stage of development of the pharmaceutical market have been identified. Recommendations for improving legislation can contribute to the development of the pharmacy sector and increase the availability of drug care.